Lopes-Ventura, S <br/><br/>
The efficacy of HRAS and CDK4/6 inhibitors in anaplastic thyroid cancer cell lines.  [electronic resource] 

 -  Journal of endocrinological investigation  May 2019 
 - 527-540 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1720-8386 
<br/><br/><label>Standard No.: </label>10.1007/s40618-018-0947-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis<br/>Cell Cycle<br/>Cell Proliferation<br/>Cyclin-Dependent Kinase 4--antagonists & inhibitors<br/>Cyclin-Dependent Kinase 6--antagonists & inhibitors<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Mutation<br/>Piperazines--administration & dosage<br/>Proto-Oncogene Proteins p21(ras)--antagonists & inhibitors<br/>Pyridines--administration & dosage<br/>Quinolones--administration & dosage<br/>Thyroid Carcinoma, Anaplastic--drug therapy<br/>Thyroid Neoplasms--drug therapy<br/>Tumor Cells, Cultured